MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Neural Correlates of Dual Task Touchscreen Performance in Parkinson’s Disease

    J. de Vleeschhauwer, N. D'Cruz, I. Orlando, J. Tan, E. Nackaerts, W. Vandenberghe, S. Lewis, M. Shine, A. Nieuwboer (Leuven, Belgium)

    Objective: To compare task-related brain activity during a touchscreen task in Parkinson’s disease (PD) patients and healthy controls (HC) in single (ST) and dual task…
  • 2024 International Congress

    Decrease in Walking Ability with Increased Functional Connectivity between Multiple Brain Areas in Parkinson’s Disease

    ZZ. Zhu, JL. Wu, NB. Yu, JD. Han, J. Wang, Y. Wang (tianjin, China)

    Objective: To compare the functional connectivity of PFC, PMC, and PSC regions during walking between individuals with Parkinson's disease and healthy controls. Background: Gait disturbances…
  • 2024 International Congress

    Associations Between Striatal Dopamine Transporter Binding and Motor Asymmetry In De Novo PD with and Without RBD

    H. Hameed, S. Elasfar, K. Ehgoetz Martens (Waterloo, Canada)

    Objective: To evaluate the associations between striatal and motor asymmetry in Parkinson’s disease with probable RBD compared to without. Background: Parkinson’s disease is typically characterized…
  • 2024 International Congress

    Synaptic Density Loss in Parkinson’s Disease Independent of Age: Preliminary Findings using [18F]SynVesT-1 PET Tracer

    S. Martin, C. Uribe, K. Desmond, N. Vasdev, A. Strafella (Toronto, Canada)

    Objective: To determine whether synaptic density differs in the brain of people with Parkinson’s disease and healthy controls using the [18F]-SynVesT-1 PET tracer. Background: The…
  • 2024 International Congress

    Cerebrovascular Reactivity and Glymphatic Clearance in Parkinson’s disease

    S. Ryman, E. Erhardt, N. Shaff, A. Dodd, N. Hoffman, S. Nitschke, K. Julio, G. Suarez-Cedeno, A. Deligtisch, D. Sugar, H. Lin, A. Vakhtin, HJ. Van-Der-Horn, S. Pirio Richardson, A. Mayer (Albuquerque, USA)

    Objective: To evaluate whether altered cerebrovascular reactivity contributes to reduced glymphatic clearance in Parkinson’s disease (PD). Background: Cerebrovascular activity is a major factor driving cerebrospinal…
  • 2024 International Congress

    Comparing 18F-AV133 VMAT2 PET and DATscan as Markers of Parkinson’s Disease Severity and Progression

    M. Miyasaka, A. Avbersek, M. Ahmed, M. Effendi, O. Harari, L. Pham, S. Somersan-Karakaya, L. Sun, O. Levy, F. Sepehrband (Tarrytown, USA)

    Objective: Compare VMAT2 PET signal with DATscan at baseline and over time, and evaluate their correlations with MDS-UPDRS III. Background: DATscan is a Parkinson’s disease…
  • 2024 International Congress

    Longitudinal change in brain function and structure related to plasma neurofilament light protein in early-stage Parkinson’s disease

    Y. Xiao, SC. Wang, YB. Hou, HF. Shang (Chengdu, China)

    Objective: We aimed to explore the relationship between the pNfL and change in the brain in early-stage PD using a longitudinal brain imaging cohort. Background:…
  • 2024 International Congress

    Increased Brain Free Water is Associated with Regional Gene Expression in Parkinson’s Disease

    D. Zhang, J. Yao, H. He, T. Wu (Beijing, China)

    Objective: In this study, we used brain free water scores and regional gene expression profiles from the Allen Human Brain Atlas transcriptomic data to investigate…
  • 2024 International Congress

    Ultrasound of Spinal Fluid Dynamics in Headache and Vertigo Patients with Central Sensitization: Novel Biomarker

    R. Bubnov (Kyiv, Ukraine)

    Objective: This study aimed to investigate the neurophysiological responses and potential mechanisms underlying the therapeutic effects of ultrasound (US)-guided dry needling in patients presenting with…
  • 2024 International Congress

    Role of RNA splicing in Parkinson’s disease

    K. Irmady, C. Hale, R. Qadri, J. Fak, T. Carroll, R. Darnell (New York, USA)

    Objective: To identify key molecular perturbations affecting medium spiny neuron functions and their role in the clinical symptoms of Parkinson’s disease (PD). Background: The degeneration…
  • « Previous Page
  • 1
  • …
  • 431
  • 432
  • 433
  • 434
  • 435
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley